Krzysztof Kuziak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Krzysztof Kuziak has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Marta Łaszcz
Pharmaceutical Research Institute, Warsaw, Poland
3 shared publications - Anna Witkowska
Pharmaceutical Research Institute, Warsaw, Poland
2 shared publications - Marek Kubiszewski
Analytical Department, Łukasiewicz Research Network—Industrial Chemistry Institute, 8 Rydygiera Str., 01-793 Warsaw, Poland
2 shared publications Agnieszka Ciesielska
Pharmaceutical Research Institute (PRI), 8 Rydygiera Street, Warsaw 01-793, Poland
1 shared publication- Andrzej Leś
R&D Analytical Chemistry Department, Pharmaceutical Research Institute, 8 Rydygiera Street, 01-793 Warsaw, Poland
1 shared publication - Elżbieta Urszula Stolarczyk
Spectrometric Methods Department, National Medicines Institute, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 22 August 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (9) , 641
Design and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active anticancer substance abiraterone (AB). The direct coupling of AB with gold constitutes an essential feature of the unique AuNPs–AB conjugate that creates a promising platform for applications in nanomedicine. In this work, we present a multidisciplinary, basic study of the obtained AuNPs–AB conjugate. Theoretical modeling based on the density functional theory (DFT) predicted that the Aun clusters would interact with abiraterone preferably at the N-side. A sharp, intense band at 1028 cm−1 was observed in the Raman spectra of the nanoparticles. The shift of this band in comparison to AB itself agrees well with the theoretical model. AB in the nanoparticles was identified by means of electrochemistry and NMR spectroscopy. The sizes of the Au crystallites measured by XRPD were about 9 and 17 nm for the nanoparticles obtained in pH 7.4 and 3.6, respectively. The size of the particles as measured by TEM was 24 and 30 nm for the nanoparticles obtained in pH 7.4 and pH 3.6, respectively. The DLS measurements revealed stable, negatively charged nanoparticles.
- 22 August 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (9) , 641
Open AccessDesign and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active anticancer substance abiraterone (AB). The direct coupling of AB with gold constitutes an essential feature of the unique AuNPs–AB conjugate that creates a promising platform for applications in nanomedicine. In this work, we present a multidisciplinary, basic study of the obtained AuNPs–AB conjugate. Theoretical modeling based on the density functional theory (DFT) predicted that the Aun clusters would interact with abiraterone preferably at the N-side. A sharp, intense band at 1028 cm−1 was observed in the Raman spectra of the nanoparticles. The shift of this band in comparison to AB itself agrees well with the theoretical model. AB in the nanoparticles was identified by means of electrochemistry and NMR spectroscopy. The sizes of the Au crystallites measured by XRPD were about 9 and 17 nm for the nanoparticles obtained in pH 7.4 and 3.6, respectively. The size of the particles as measured by TEM was 24 and 30 nm for the nanoparticles obtained in pH 7.4 and pH 3.6, respectively. The DLS measurements revealed stable, negatively charged nanoparticles.
- 1 August 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (8) , 2419-2426
Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs
- 1 August 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (8) , 2419-2426
Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs
- Open Access
Identification and Physicochemical Characteristics of Temozolomide Process-Related Impurities
In this article the crystal structures of the starting material TZ-5 and the key intermediate TZ-6 of temozolomide (TZ-7), an anticancer therapeutic agent, are presented, together with their spectroscopic and thermal characteristics. Both compounds crystallize in the triclinic P-1 space group. X-ray crystallography studies proved that the compound TZ-6 exists as a monohydrate. A complete structural assignment was obtained for the signals in the 1H-, 13C- and 15N-nuclear magnetic resonance spectra and the structures were confirmed by Fourier-Transform infrared and Raman spectroscopy. The article describes the importance of the high purity of TZ-6 during the small-scale plant production of TZ-7 in a desired polymorphic form III with the purity higher than 99.50%, according to an HPLC method.
Open AccessIdentification and Physicochemical Characteristics of Temozolomide Process-Related Impurities
In this article the crystal structures of the starting material TZ-5 and the key intermediate TZ-6 of temozolomide (TZ-7), an anticancer therapeutic agent, are presented, together with their spectroscopic and thermal characteristics. Both compounds crystallize in the triclinic P-1 space group. X-ray crystallography studies proved that the compound TZ-6 exists as a monohydrate. A complete structural assignment was obtained for the signals in the 1H-, 13C- and 15N-nuclear magnetic resonance spectra and the structures were confirmed by Fourier-Transform infrared and Raman spectroscopy. The article describes the importance of the high purity of TZ-6 during the small-scale plant production of TZ-7 in a desired polymorphic form III with the purity higher than 99.50%, according to an HPLC method.